Inflammation of the mammary gland (mastitis) is an important disease of dairy sheep. Mastitis management depends mainly on the diagnosis. Conventional diagnostic methods including somatic cell count, California Mastitis Test, and microbial culture have limitations. Therefore researchers are looking for new diagnostic biomarkers of mastitis including specific proteins produced by the liver in case of disease (acute phase proteins), unique genetic sequences (miRNAs), or antimicrobial peptides produced by immune cells during inflammation (cathelicidines).
Mammary gland inflammation (mastitis) is one of the most costly and severe diseases in the dairy industry [1]. Negative impact does not only refer to economic reasons but also significantly contributes to animals’ health and consequently their welfare. Another important perspective is the food safety (food-borne diseases) and quality of dairy products (such as cheese) since milk from affected animals may contain pathogenic bacteria and has altered composition undesired by the dairy industry [2][3]. From a global point of view, the most important dairy species are cattle, producing over 80% of world milk production [4] followed by buffaloes with 15%, goats with 2% (accounts for about 1000 million head, of which 20% intended for dairy production) and sheep with 1% (accounts for almost 1200 million head, of which 25% intended for dairy production); camels provide 0.5% and 1.5% comes from other dairy species [4]. Consequently, mastitis in cattle is a well-recognized problem, to which researchers and bovine practitioners all around the world pay special attention. Nevertheless, in some countries due to climate and/or traditional or historical reasons milk is derived from other than cattle dairy species, for example, from small ruminants [5]. Goats and sheep are often kept in an environment with scarce grazing and unfavorable climatic conditions. In some countries, they are considered as dairy animals of the poor because of the lower capital investment and low production costs required [6]. They are also characterized by rapid generation turnover (and thus earlier milk production compared with other dairy animals), short pregnancies, and milk supply in quantities that are suitable for immediate household consumption (thereby reducing problems of milk storage and marketing) [5].
However, at the same time, small ruminants become more and more popular in highly developed countries since they perfectly fit into the conception of organic farming or are kept as pets, in particular in suburban areas [7][8]. Although sheep and goats are not demanding animals, they can provide products of great quality. Ewe’s milk contains higher levels of total solids (protein and fat) and more major nutrients than goat and cow milk. To compare, sheep milk contains 5.5 ± 1.1 g/100 g of protein and 5.9 ± 0.3 g/100 g of fat, while cow milk contains 3.4 ± 0.1 g/100 g and 3.3 ± 0.2 g/100 g of these solids, respectively [9]. Consequently, ewe’s milk is characterized by excellent cheese-making properties, thus is consumed rarely in liquid form. Apart from that, there is one compound in ruminants’ milk—conjugated linoleic acid (CLA), the most abundant in sheep milk, that may have far-reaching, positive effects on milk consumption [10]. CLA has been shown to have numerous potential benefits for human health, including potent cancer-fighting properties [10]. Sheep milk-producing farms represent a significant part of the agrarian economies in many countries, especially those bordering the Mediterranean Sea and in the Middle East [9]. Moreover, it is important to highlight that dairy sheep are suitable for organic agriculture, involving a long period of grazing, great care for animal welfare, and reduced use of antibiotics and hormones. The bio (organic) products derived from organic farming are more and more popular in highly developed countries and this trend is expected to continue [11].
Sheep are believed to be one of the first domesticated species and probably the problem of udder inflammation has been present since then [1]. Regarding mastitis in sheep the literature reports individual milk yield losses of 2.6–43.1% [2], being modulated by several factors including infection severity, production level, causal agents, and unilateral or bilateral infection. Mastitis not only negatively affects milk yield but also alters milk quality [7]. The impairment of physical and chemical characteristics due to decreased udder health status is responsible for the negative effect of increased somatic cell count on the coagulation properties of milk, the curd yield, and the quality of cheese [2], which does not allow producers to meet the quality standards required by consumers, industry and public health organizations [12]. A low ratio of casein to protein in high bulk tank somatic cell count (BTSCC) milk enhances the extension of the rennet coagulation time and curd firming time because there are more serum proteins, and the stability of casein micelles are reduced as a result of hydrolysis. Those changes, in turn, led to poor syneresis, lower cheese yield, increased moisture content, and lower fat and protein content in cheese [2].
Another important issue is public health in terms of consuming cheese made from infected milk, in particular, some traditional kinds of cheeses without milk pasteurization. Globally only 25% of sheep are intended for dairy production [13]. In many countries, most sheep are kept for the production of meat and therefore most studies focus on symptoms of mastitis occurring in ewes that are nursing lambs. In these flocks, only severe clinical mastitis is likely to be observed and diagnosed. According to Ruegg [14], this lack of emphasis on milking ewes has led to an over-emphasis on the occurrence of clinical mastitis and a lack of appreciation for subclinical mastitis. Clinical mastitis (CM) typically occurs in <5% of lactating ewes, but subclinical mastitis (SM) may occur in 15–30% of animals [14]. The information regarding mastitis prevalence in different management systems is given in Table 1 . Among the etiologic agents, the most prevalent are Coagulase-negative staphylococci (CNS), Corynebacterium sp., while Streptococcus spp. , Enterobacteriaceae , Pseudomonas aeruginosa , Mannheimia haemolytica , Corynebacterium spp. , and fungi can also cause mastitis in sheep, but are observed at relatively lower rates [1]. Mastitis is considered one of the most significant reasons for premature culling in dairy sheep in the United Kingdom [15]. In the United States, udder-health issues account for about 14% of ewes culled each year [16]. There is no general consensus about the prevalence of mastitis in sheep of different breeds and from various areas. It has been reported that the culling of ewes resulting from clinical mastitis episodes can reach up to 70% [17] or even 90% [1]. Therefore, proper diagnosis is a critical aspect of preventing mastitis and its economic consequences. A significant role in mastitis control in the flock seems to have the udder health management at the end of the lactation period when the mammary gland is particularly prone to infections [18] and immediate or delayed culling. The elimination of existing subclinical infections relies on the intramammary application of antibiotics at drying-off and removing ewes affected by acute or chronic mastitis from the flock until culling or complete recovery [19]. Nevertheless, to identify the ewes with SM, laboratory diagnostics is crucial.
Management System | Prevalence of Subclinical Mastitis | References |
---|---|---|
Semi-intensive | 0.296 | [20] |
0.120 | [21] | |
0.112 | [22] | |
Intensive | 0.254 | [20] |
Semi-extensive | 0.196 | [20] |
0.192 | [23] | |
0.139 | [24] | |
Extensive | 0.178 | [20] |
0.192 | [23] |
A permanent search is underway for other indicators of inflammation that would enable more efficient, sensitive, and specific detection of mastitis. These indicators should constitute an alternative to SCC or as a supplement for evaluation or improving SCC performance [40][41]. Researchers should look for the molecules that are released into the milk by the mammary gland during inflammation. This indicator should be a molecule, enzyme, or protein that is practical for detection with enzymatic assays or other immunoassay procedures [40]. Recent investigations and data carried over from humans, as well as veterinary medicine, show that acute-phase proteins (APP), microRNAs (miRNAs; short, non-coding RNAs), and cathelicidins measurement may be the tools needed to improve the early diagnostics of ovine mastitis [42][43][44].
This entry is adapted from the peer-reviewed paper 10.3390/ani11102783